FONAR sells two more UPRIGHT Multi-Position MRI scanners

NewsGuard 100/100 Score

FONAR Corporation (NASDAQ: FONR) announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.

Raymond Damadian, president and founder of FONAR said, "We are pleased to have two more medical practices purchase the UPRIGHT® MRI. These practices recognize that there is no other acceptable way to image the spine. It is also encouraging to note that they purchased the UPRIGHT® MRI despite widespread confusion in healthcare reimbursement because the medical practices realize that the best technology enables the best opportunities.

Medical practices that have experience with the FONAR UPRIGHT® MRI are enthusiastic about its unique capabilities. For example, at the recently re-opened East Bay Upright MRI in Hayward, California, Neuroradiologist J. Randy Jinkins, MD, FACR, FEC, said, "The FONAR UPRIGHT® MRI has become the new standard of care because it is the only MRI able to put the patient in the position that generates symptoms. This will allow the referring doctors to be able to make far more comprehensive and accurate evaluations of their patients' conditions."

The two new sales continue the positive trend that FONAR established during the past year, as reported on October 5th when the Company announced its financial results for the fiscal year ending June 30, 2009. Total net income was $1.1 million, as compared to a net loss of $13.5 million the previous year. In addition, this compares to a loss of $25.5 million in fiscal 2007 and a loss of $30.0 million in fiscal 2006. Total revenues increased by 12% to $39.7 million for the fiscal year ended June 30, 2009, as compared to $35.6 million for the previous fiscal year.

Dr. Damadian commented, "Given the increasing awareness of the medical community as to the unique diagnostic advantages of the FONAR UPRIGHT® Multi-Position™ MRI, we are very hopeful that the positive trend that FONAR has demonstrated will grow over time."

SOURCE: FONAR Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.